Total Payments
$38,463
2024 Payments
$4,957
Companies
59
Transactions
1,177
Medicare Patients
29,185
Medicare Billing
$2.0M
Payment Breakdown by Category
Food & Beverage$21,413 (55.7%)
Other$10,610 (27.6%)
Travel$6,329 (16.5%)
Gifts$75.13 (0.2%)
Education$35.81 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,413 | 1,141 | 55.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,600 | 4 | 27.6% |
| Travel and Lodging | $6,329 | 25 | 16.5% |
| Gift | $75.13 | 1 | 0.2% |
| Education | $35.81 | 5 | 0.1% |
| Entertainment | $9.94 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $12,958 | 153 | $0 (2024) |
| Abbott Laboratories | $6,176 | 96 | $0 (2024) |
| Boston Scientific Corporation | $3,013 | 32 | $0 (2023) |
| ABIOMED | $2,105 | 47 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,474 | 103 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,454 | 72 | $0 (2020) |
| PFIZER INC. | $1,303 | 100 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,159 | 76 | $0 (2024) |
| Amgen Inc. | $1,036 | 80 | $0 (2024) |
| Merck Sharp & Dohme LLC | $695.98 | 32 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,957 | 134 | Abbott Laboratories ($2,851) |
| 2023 | $6,689 | 134 | Abbott Laboratories ($2,465) |
| 2022 | $3,141 | 159 | ABIOMED ($707.33) |
| 2021 | $2,764 | 148 | ABIOMED ($402.68) |
| 2020 | $1,148 | 69 | Janssen Pharmaceuticals, Inc ($240.44) |
| 2019 | $5,202 | 175 | Novartis Pharmaceuticals Corporation ($3,013) |
| 2018 | $11,309 | 185 | Novartis Pharmaceuticals Corporation ($8,370) |
| 2017 | $3,252 | 173 | BOSTON SCIENTIFIC CORPORATION ($483.66) |
All Payment Transactions
1,177 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/30/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $1.33 | General |
| Category: Vascular | ||||||
| 12/27/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $9.14 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/24/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Heart Failure | ||||||
| 12/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/11/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.34 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/10/2024 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $90.85 | General |
| Category: Peripheral Intervention | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $31.41 | General |
| Category: Medical Device | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $34.27 | General |
| 11/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.97 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/07/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/06/2024 | BIOTRONIK INC. | Acticor 7 VR-T DX (Device) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $27.15 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/04/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.45 | General |
| Category: Cardiovascular | ||||||
| 10/31/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Heart Failure | ||||||
| 10/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Obesity | ||||||
| 10/28/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $13.15 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $16.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 47 | 7,221 | 11,019 | $3.9M | $509,058 |
| 2022 | 49 | 6,898 | 10,212 | $4.2M | $468,876 |
| 2021 | 54 | 7,271 | 10,510 | $4.4M | $491,940 |
| 2020 | 55 | 7,795 | 10,881 | $4.8M | $499,546 |
Total Patients
29,185
Total Services
42,622
Medicare Billing
$2.0M
Procedure Codes
213
All Medicare Procedures & Services
213 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 1,117 | 2,633 | $460,775 | $176,460 | 38.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 865 | 939 | $244,385 | $46,654 | 19.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 261 | 677 | $159,772 | $40,494 | 25.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 251 | 295 | $197,355 | $37,404 | 19.0% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 157 | 162 | $751,680 | $30,208 | 4.0% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 42 | 51 | $188,700 | $19,097 | 10.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 154 | 154 | $40,964 | $14,317 | 34.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 122 | 208 | $36,400 | $12,660 | 34.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 232 | 236 | $708,000 | $12,504 | 1.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,366 | 2,140 | $154,000 | $12,478 | 8.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Facility | 2023 | 95 | 112 | $28,560 | $11,743 | 41.1% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2023 | 137 | 454 | $29,510 | $9,111 | 30.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 74 | 87 | $15,225 | $7,285 | 47.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 217 | 221 | $91,597 | $5,910 | 6.5% |
| 33274 | Insertion of permanent leadless pacemaker using imaging guidance | Facility | 2023 | 15 | 15 | $20,025 | $5,283 | 26.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 43 | 58 | $20,648 | $5,181 | 25.1% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Facility | 2023 | 187 | 206 | $68,645 | $5,060 | 7.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Facility | 2023 | 414 | 502 | $28,614 | $4,959 | 17.3% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 11 | 11 | $37,070 | $4,007 | 10.8% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Facility | 2023 | 30 | 197 | $9,850 | $3,653 | 37.1% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 211 | 214 | $21,400 | $3,233 | 15.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 67 | 68 | $7,480 | $3,055 | 40.8% |
| 93280 | Programming of dual lead pacemaker system | Facility | 2023 | 86 | 111 | $12,765 | $3,032 | 23.8% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 11 | 11 | $60,500 | $2,882 | 4.8% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 17 | 17 | $87,380 | $2,779 | 3.2% |
About Dr. Antoine Rizk, M.D
Dr. Antoine Rizk, M.D is a Cardiovascular Disease healthcare provider based in Biloxi, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568411403.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Antoine Rizk, M.D has received a total of $38,463 in payments from pharmaceutical and medical device companies, with $4,957 received in 2024. These payments were reported across 1,177 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($21,413).
As a Medicare-enrolled provider, Rizk has provided services to 29,185 Medicare beneficiaries, totaling 42,622 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 213 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Biloxi, MS
- Active Since 05/09/2006
- Last Updated 09/23/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1568411403
Products in Payments
- ENTRESTO (Drug) $12,353
- AVEIR (Device) $4,730
- Impella (Device) $2,105
- ELIQUIS (Drug) $1,743
- XARELTO (Drug) $1,474
- JARDIANCE (Drug) $849.01
- Micra (Device) $807.70
- VERQUVO (Drug) $695.98
- LEQVIO (Drug) $604.99
- Repatha (Biological) $586.66
- Corlanor (Drug) $412.75
- CARDIOMEMS (Device) $408.75
- KENGREAL (Drug) $386.76
- OPSUMIT (Drug) $377.59
- CardioMEMS HF System (Device) $311.78
- PRADAXA (Drug) $310.30
- PRALUENT (Drug) $292.42
- SQ-RX PULSE GENERATOR (Device) $240.76
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $226.06
- WATCHMAN (Device) $223.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Biloxi
Paul Mullen, M.d, M.D
Cardiovascular Disease — Payments: $36,368
Cardiovascular Disease $36,368
Jack Brand, Md, MD
Cardiovascular Disease — Payments: $7,173
Cardiovascular Disease $7,173
Eva Magiros, M.d, M.D
Cardiovascular Disease — Payments: $3,535
Cardiovascular Disease $3,535
Dr. Gilberto Patino, Md, MD
Cardiovascular Disease — Payments: $2,210
Cardiovascular Disease $2,210
Dr. Alexander Yuan, D.o, D.O
Cardiovascular Disease — Payments: $202.90
Cardiovascular Disease $202.90